UIC Law Review

PDF

Optrex and the Attorney-Client Privilege: Implications and Potential Significance, 39 J. Marshall L. Rev. 1 (2005)
Sandra Liss Friedman and Helena D. Sullivan

PDF

Remands in Trade Adjustment Assistance Cases, 39 J. Marshall L. Rev. 9 (2005)
Munford Page Hall II

PDF

An Importer's Election: Whether to Invoke Attorney Advice in Defense or to Preserve Privilege, 39 J. Marshall L. Rev. 17 (2005)
Patricia M. McCarthy

PDF

What Does Optrex Mean for the Customs Bar?, 39 J. Marshall L. Rev. 23 (2005)
John B. Pellegrini

Preliminary Injunctions: A Respondent's Perspective, 39 J. Marshall L. Rev. 29 (2005)
Stuart M. Rosen, Jennifer J. Rhodes, and W. Andrew Ryu

PDF

Injunctions Against Liquidation in Trade Remedy Cases: A Petitioner's View, 39 J. Marshall L. Rev. 45 (2005)
Jeffrey M. Telep

PDF

Adjudicating International Trade Cases at the U.S. Commerce Department: Endless Remand or Balanced Resolve?, 39 J. Marshall L. Rev. 59 (2005)
Elizabeth C. Seastrum and Matthew D. Walden

PDF

Patients Beware: Preemption of Common Law Claims Under the Medical Device Amendments, 39 J. Marshall L. Rev. 75 (2005)
Michael P. DiNatale

PDF

Regulating the Regulators: The Impact of FDA Regulation on Corporations' First Amendment Rights, 39 J. Marshall L. Rev. 95 (2005)
Lisa M. Fealk-Stickler

PDF

American Courts are Drowning in the "Gene Pool": Excavating the Slippery Slope Mechanisms Behind Judicial Endorsement of DNA Databases, 39 J. Marshall L. Rev. 115 (2005)
Meghan Riley

PDF

Public Use or Experimental Use: Are Clinical Trials Susceptible to Another Attack Similar to That in Smithkline Beecham Corp. v. Apotex Corp., 39 J. Marshall L. Rev. 149 (2005)
Nimalka Wickramasekera